Laboratory Management
Collapse AMP 2016 Annual Meeting Highlights - Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory
Recordings of Selected Presentations

Please note that this webinar was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.

This collection will give you access to the recordings of the presentations (listed below) and pdf slides only. CME/CMLE or SAM is not available for this collection


Description:

Did you miss out on joining us in Charlotte for the AMP 2016 Annual Meeting? Were you there but missed something you really wanted to see? We have you covered with the AMP 2016 Annual Meeting Highlights. Select presentations were recorded and are now available for online viewing.

 

Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory

As tests for large numbers of rare genetic conditions come on-line in clinical laboratories, it is becoming increasing difficult to obtain high-quality, well-characterized human samples to use for the purposes of test development, validation, and ongoing proficiency testing. The first presentation will review how the CDC GeT-RM program is helping laboratories access samples for these purposes. Non-invasive prenatal screening (NIPS) for the common triploidies, Down (T21), Edward (T18) and Patau (T13) syndromes, as well as numerical abnormalities of the sex chromosomes, is now firmly established as an extremely valuable screening tool. However, there is currently no universally accepted or adopted proficiency test (PT) for NIPS. The second presentation will review the substantial challenges in developing PT for NIPS, and review progress in its development.

- Identify the sample resources available to laboratories through the Get-RM program.

- Explain the challenges and current progress toward developing PT samples for NIPS testing.

 

Development of Reference Materials for Proficiency Testing and Quality Assurance

Lisa V. Kalman, PhD, Centers for Disease Control and Prevention, Atlanta, GA, USA

External Proficiency Assessment of Prenatal Cell Free (cf )DNA Testing for Aneuploidy

Glenn E. Palomaki, PhD, Women & Infants Hospital, Providence, RI, USA

Duration1.5 hr

Recording Date: November 10, 2016


You might also be interested in:

NoteJoin the AMP Family to purchase many of the content for a deep discount!

Formats Available: AMP 2016 Highlights - Kalman & Palomaki
Original Course Date: November 10, 2016
On-Demand Release Date: Available Now
MORE INFOMORE INFO AMP 2016 Annual Meeting Highlights - Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory
Collapse AMP 2019 Molecular Genetic Pathology (MGP) Online Self-Study Review Course (+CME/CMLE and SAM)

 

 

This online course includes all the recorded presentations, course materials, case studies, and tests from the live course held on May 16-19, 2019. CME/CMLE or SAMs is available with the purchase of this course until December 31, 2020.


This course features an intense update and review of molecular diagnostics for those prepping for the Molecular Genetic Pathology (MGP) Subspecialty Certification Exam as well as other certification exams, those who need a refresher, or anyone looking to add molecular testing to their current pathology practice. Participants have the opportunity to learn directly from recognized experts in the field of molecular pathology. Learn at your own pace and rewatch lectures as many times as you'd like.

Go here for more information on the course. 

Duration

The course will be available to purchase until December 31, 2020 (11:59PM Eastern), but please note that the course will also expire in your classroom on December 31, 2020. If you need access beyond December 31, please email AMPEducation@amp.org and we will consider a limited extension on a case-by-case basis. 

Note - registrants who attended the face-to-face course do not need to register for the online course to access the online materials.


CME/CMLE credit and SAMs credit are both available with the purchase of this course.

Credit Type Number of Credit Hours
CME/CMLE 20.75
SAMs 19.50
Continuing Education Credit must be claimed by December 31, 2020

* You may not submit SAMs and CME/CMLE credit for the same content.

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Association for Molecular Pathology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring activity for a maximum of 20.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensuratesam with the extent of their participation in the activity. 

SAM Credit: The AMP 2019 MGP Review Course is approved by the American Board of Pathology for up to 19.50 SAM credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. Learners must pass the post-test with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available.  If you are seeking continuing education credit for an accrediting board other than the ABP, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).



Note: Members of AMP can access this course for a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

Formats Available: MGP Review Course 2019 - Online Self Study
Original Course Date: May 16, 2019
On-Demand Release Date: Available Now
MORE INFOMORE INFO AMP 2019 Molecular Genetic Pathology (MGP) Online Self-Study Review Course (+CME/CMLE and SAM)
Collapse AMP Global 2019: Handouts
Global Congress on Molecular Pathology

This collection contains downloadable PDF slides of many of the presentations given during the AMP Global 2019 (May 16 - May 18, 2019).  Click here for more information about the meeting.

 

The digital files (PDFs) from AMP Global 2019 are:

  • Free for all AMP members until August 31, 2019. After August 31, 2019 (12:00 PM EST), the price increases to $99.00.
  • Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until August 31, 2019.

 

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

How to Purchase and Access the Presentation Slides

  1. On the menu to the right, click on "add to basket"
  2. Log in using your AMP credentials.
  3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
  4. Check out.
  5. Click here for instructions on how to access the presentation slides.

You may also be interested in:

Join the AMP Family for a discount on this item.

Formats Available: AMP Global 2019: Handouts
Original Course Date: May 16, 2019
MORE INFOMORE INFO AMP Global 2019: Handouts
Collapse The ABCs of CPT<sup>®</sup> Coding (CE Available)
A Webinar Presented by the AMP Economic Affairs Committee

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


Description:

Knowledge of the coding structure of molecular medicine is crucial as these codes are incorporated and used by insurers to identify the services you provide to patients and understanding the basics of CPT® coding will benefit your laboratory practice and management. The American Medical Association (AMA) Current Procedural Terminology (CPT®) coding system is used throughout the United States as a main system of coding for health care services, including laboratory and pathology procedures. The AMP Economic Affairs Committee (EAC) is intimately involved in this process, both by submitting code change applications regularly but also by occupying a rotating seat on the Pathology Coding Caucus, which reviews and provides recommendations to the AMA CPT® Editorial Panel on applications for new or revised pathology and laboratory services. During this webinar, AMP members will be provided with a better understanding of the intricacies of the CPT® coding structure and process for laboratory and pathology codes. This webinar will also educate members by providing resources and tips for submitting your own code change application.


Speakers: Anthony N. Sireci, MD;  Aaron D. Bossler, MD, PhD; and Victoria M. Pratt, PhD

Moderator: Cecilia S. Yeung, MD

Duration: 1 hr

Level of Instruction: Basic


Click on the links below to purchase continuing education credit.

Credit Type Number of Credit Hours Click on link to purchase:
CME/CMLE 1.0

Purchase Webinar + CME/CMLE

(Just $5.00 USD for AMP members)

Continuing Education Credit must be purchased and claimed by Sept 18, 2021

 

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Formats Available: Streaming
Original Course Date: September 18, 2018
MORE INFOMORE INFO The ABCs of CPT<sup>®</sup> Coding (CE Available)
Collapse The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer

Please note that this webinar was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.

AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.


Recent definitions for clinical utility of molecular tests focus on whether a test result will alter treatment. This definition neglects other uses of molecular testing to diagnose disease, manage symptoms, prognosticate or predict future disease. The fullest realization of precision medicine will require embracing all aspects of clinical utility. This three-part webinar series, supported by AMP, presents the discussions of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility (FEND) working group, and its resulting publication, “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology” (Joseph L, et al. J Mol Diagn. 2016;18[5]:605–619).

 

Part 1 - An Overview of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility

Speakers: Loren Joseph, MD; Elaine Lyon, PhD

Host: Roger Klein, MD, JD

 

Part 2 - AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Oncology Cases

Speakers: Pranil Chandra, DO, FCAP, FASP; Rajyasree Emmadi, MD, FCAP

Host: Loren Joseph, MD

 

Part 3: AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Inherited Conditions

Speakers: Stephanie Hallam, PhD, FACMG, MBA; Victoria Pratt, PhD, FACMG

Host: Elaine Lyon, PhD

Practice Guideline Available Here

Total Duration: 3 hr

Level of Instruction: Advanced

 

You might also be interested in:

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

Formats Available: Streaming
Original Course Date: September 28, 2016
MORE INFOMORE INFO The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer